Desq Long
Sign in
SEC FORM 4
—

NovaBridge Biosciences (NBP)

Acquisition (code M) of 9,382 shares; price not stated (see filing).

Reporting Person Xu Cong Claire · Officer Title EVP, Clinical Development · Transaction Code M

Traded Aug 30, 2026 · Disclosed Sep 1, 2026

Source: SEC Form 4 · 0002114309-26-000007 · filed 2026-09-01 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "NovaBridge Biosciences (NBP)." Disclosed 2026-09-01. https://desqlong.com/cards/0002114309-26-000007-1 (retrieved 2026-09-26).